Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
The peptide's peak neurotransmitter effects occur within 2-6 hours of injection
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist available in the US under two brand names: Mounjaro (for type 2 diabetes in adults) and Zepbound (for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity)
You can return to work, errands, or exercise immediately Many patients notice increased energy, improved mood, and greater mental clarity immediately after treatment
On April 15, 2026, the FDA announced the removal of BPC-157 from its 503A Category 2 list, effective April 22, 2026, because the original nominations were withdrawn
